Effects of fasting, refeeding, and intraluminal triglyceride on proglucagon expression in jejunum and ileum

Diabetes

Volumn 45, Issue 4, 1996, Pages 434-439

  Hoyt, Eileen C ^a   Lund, P Kay ^a,b   Winesett, Douglas E ^a   Fuller, C Randall ^a   Ghatei, Mohammed A ^c   Bloom, Stephen R ^c   Ulshen, Martin H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCAGON LIKE PEPTIDE 1; MESSENGER RNA; PROGLUCAGON; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME LOCALIZATION; GENE EXPRESSION REGULATION; ILEUM; JEJUNUM; LIPID METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REFEEDING;

EID: 0029921394     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.4.434     Document Type: Article

References (31)

1. Mosjov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF Preproglucagon gene expression diversifies at the level of post-translational processing. J Biol Chem 262:11880-11889, 1986
2. Orskov C: Glucagon-like peptido I. a new hormone of the entero-insular axis. Diabetologia 35:701-711, 1992
3. Holst JJ: Gut glucagon, enteroglucagon, gut glueagonlike immunoreactivity, ghcentin-cutrent status. Gastroeulerolugy 84:1602-1613, 1983
4. Dubrasquet M, Bataille D, Gespach C: Oxyntomodulin (gluragon-37 or btoactive enteroglucagon) a potent mhibitor of pentagastrin stimulated acid secretions in rats Biosci Rep 2:301-390, 1982
5. Schjoldager B, Poul EM, Myhre J, Christiansen J, Holst JJ: Oxyntomodulin from distal gut: role in regulation of gastric and pancreatic functions Dig Dis Sci 34:1411-1-419, 1989
6. Orskov C. Holst JJ, Knuhtsen S, Baldissera FGA, Poulson SS, Nielson OV, Glucagon-like peptides GLP-I and GLP-II, predicted products of the glueagon gene are secreted separately from the pig small intestine but not pancreas. J Biol Chem 2658001-8008, 1986
7. Orskov C, Bersani M, Jolmsen AJ, Hojrup K, Holst JJ: Complete sequences of glucagon-like peptide I from human and pig small intestine J Biol Chem 264:12826-12829, 1989
8. MOJSOV S, Kopczynski MG, Habener JF: Both amidated and non-amdated forms of glucagon-like peptide are synthesized in the rat intestine and the pancreas. J Biol Chem 265:8001-8008, 1990
9. Schjoldager BGT, Mortensen PE, Christiansen J, Orskov C, Hoist JJ: GLP-I (glucagon-hke peptide-I) and truncated GLP-I, fragments of human proglucagon, inhibit gastric acid secretion in man. Dig Dis Sci 35: 703-708, 1989
10. O'Halloran DJ, N'ikou GC, Kreyinan B, Ghalei MA, Bloom SR: Glucagonlike peptide I (7-36)-NH2: a physiological inhibitor of the gastric acid secretion in man. J Endocrtaol 126:169-173, 1990
11. Fohmann HC, Goke R, Goke B Glucagon-like peptide 1 (7-37)/7-36 amido is a new increlin Mol Cell Endocrinol 85:C39-C44, 1992
12. Kreymann B, Williams G, Ghatei MA, Bloom SR, Glucagon-like peptide-I 7-36 amide: a physiological mcretin in man Lancet ii:1300-1303, 1987
13. Gutniak M, Orskov C, Hoist JJ, Ahren B, Efendic S: Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N Engt J Med 326:1316-1322, 1992
14. Nathan U, Schreiber E, Fogel H, Mojsov S, Habener JF Insulinoplropic action of glucagon-like peptide (7-37) in diabetic human subjects Diabetes Care 15:270-276, 1992
15. Kolligs F, Fehmann HC, Goke R, Goke B: Reduction of the mcretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. Diabetes 44:16-19, 1995
16. Wang Z, Wang KM, Owji AA, Smith DM, Ghatei MA, Bloom SR, Glucagonlike peputide 1 is a physiological incretin in rat. J Clin Invest 95:417-421, 1995
17. Moody AJ: Gut glucagon-like immunoreactivity. Clin Gastroenertot 33: 1080-1086, 1980
18. Eissele R, Goke R, Willemer S, Harthus HP, Vermeer H, Arnold R. Goke B: Glucagon-like peptide-I cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22:283-291, 1992
19. Orskov C, Jeppesen J, Madsbad S, Holst J: Preglucagon products in plasma of non-insulin dependent diabetics and non diabetic controls in fasting state and following oral glucose and intravenous arginine. J Clin Invest 87:415-423, 1991
20. Namba M, Itoh H, Watarabe N: Multiple forms of glucagon-like peptide 1 and glucagon-like immunoreactivitios in canine gastrointestinal tract and their release into the circulation Bio Mecl Res 11:247-251, 1990
21. Holst JJ, Orskov O: Glucagon and other proglucagon derived peptides In Gut Peptides Walsh JH, Dockray GJ, Eds. New York, Raven, 1994, p. 305-340
22. Fehmann HC, Goke B: Meeting report from the international symposium on GLP-I. In Trends in Endocrinology and Metabolism. Vol. 4, no. 8. Amsterdam, Elsevier, 1993, p. 253-254
23. Lund PK, Moats-Staats BM, Hynes MA, Simmuns JG, Jansen M, D'Ercole AJ, Van Wyk JJ. Somatomedin-C/IGF-I and IGF-II mRNAs in rat fetal and adult tissues. J Biol Chem 261:14539-14544, 1986
24. Heinirich G, Gros P, Lund PK, Bentley RC, Habener JF: Pre-proghicagon messenger RNA: nucleotide and encoded amino acid sequences of the rat pancreatic cDNA. Endocriology 115:2176-2182, 1984
25. Feinberg AP, Vogelstein B: A technique for radiolabcling DNA restriction endomiclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
26. Jin CSL, Hynes MA, Lund PK: Ontogeny of glucagon messenger RNA and encoded precursor in the rat intestine Regul Pept 29:117-131, 1990
27. Zimmermann E, Sartor B, McCall RD, Pardo M, Lund PK, IGF-I and IL-1B messenger RNA in a rat model of granulomatous enterocolitis and hepatitis. Oastronenterology 105:399-409, 1993
28. Ghatei MA, Uttenthal LO, Bryant MG, Christofldes ND, Moody AJ, Bloom SR: Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas. Endocrinol 112:917-923, 1983
29. George SK, Uttenthal LO, Ghiglione M, Bloom SR: Molecular forms of glucagon-like peptides in man. FEBS Lett 192:275-278, 1985
30. Takahashi J, Noma Y, Yoshirooto S, Fujita C, Shima K: Decrease in plasma GLP-1 immunoreactivity in starved rats. Diabetes Res Clin Pract 15:205-212, 1992
31. Roberge JN, Brubaker PL Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133:233-240, 1993